Baseline subfoveal choroidal thickness portends amount of decrease in fovea, central macula after anti-VEGF treatment

ORLANDO, Fla. — Eyes with thinner baseline subfoveal choroidal thickness decreased more rapidly in foveal thickness and central macular thickness after intravitreal anti-VEGF injections, according to a poster presentation here. “We demonstrate eyes with thicker baseline subfoveal choroidal thickness (SFCT) had greater anatomic and visual gains after three serial intravitreal anti-VEGF injections,” Nika Bagheri, MD, and colleagues said in the poster at the Association for Research in Vision and Ophthalmology meeting.

Full Story →